Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization - Tabular View

Tracking Information

First Received Date ^ICMJE

September 14, 2005

Last Updated Date

March 10, 2006

Start Date ^ICMJE

September 2005

Primary Completion Date

Current Primary Outcome Measures ^ICMJE

Original Primary Outcome Measures ^ICMJE

Change History

Complete list of historical versions of study NCT00199628 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Original Secondary Outcome Measures ^ICMJE

Descriptive Information

Brief Title ^ICMJE

Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization

Official Title ^ICMJE

Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization

Brief Summary

Problems of compatibility between a mother and her child are frequent. The most well-known case can be illustrated by the fetomaternal blood group incompatibility (rhesus factor) which can induce severe anemia of the fetus.

The investigators recently proved that incompatibility between mother and child can concern an organ leading to a tissular alloimmunization. For example, neonatal membranous glomerulonephritis (a kidney disease) can result from this mechanism.

The purpose of this network is to detect and study neonatal diseases induced by tissular fetomaternal alloimmunization. The detection of these diseases will be performed by the mother's serum analysis.

Detailed Description

Study Phase

Study Type ^ICMJE

Observational

Study Design ^ICMJE

Longitudinal, Defined Population, Prospective Study

Condition ^ICMJE

Glomerulonephritis, Membranous
Neonatal Diseases and Abnormalities
Hemochromatosis

Intervention ^ICMJE

Study Arms / Comparison Groups

Publications *

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Recruiting

Enrollment ^ICMJE

100

Completion Date

Primary Completion Date

Eligibility Criteria ^ICMJE

Inclusion Criteria:

Mothers having a child suffering from:

Neonatal membranous glomerulonephritis
Unexplained neonatal tubular defect
Unexplained thrombotic microangiopathy
Neonatal hemochromatosis

Exclusion Criteria:

Any cause explaining the child's disease

Gender

Female

Ages

Accepts Healthy Volunteers

Contacts ^ICMJE

Contact: Vincent Guigonis, MD

+33(0)555 056 358

vincent.guigonis@chu-limoges.fr

Location Countries ^ICMJE

France

Administrative Information

NCT ID ^ICMJE

NCT00199628

Responsible Party

Study ID Numbers ^ICMJE

I05001

Study Sponsor ^ICMJE

University Hospital, Limoges

Collaborators ^ICMJE

Investigators ^ICMJE

Principal Investigator:

Vincent Guigonis, MD

Department of Pediatrics, Limoges University Hospital

Information Provided By

University Hospital, Limoges

Verification Date

September 2005

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP